Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212‐2 alters migration of early‐born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex - Saez - 2014 - Journal
4 Dose-dependent induction of cannabinoid tetrad effects by the SCB WIN... | Download Scientific Diagram
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
Induction of Apoptosis by Cannabinoids in Prostate and Colon Cancer Cells Is Phosphatase Dependent | Anticancer Research
The effect of the cannabinoid receptor antagonist AM251 on WIN 55,... | Download Scientific Diagram
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
What is a cannabinoid? — Why Not THC
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
WIN55,212-2 (WIN), a cannabinoid receptor agonist, suppresses EPSCs... | Download Scientific Diagram
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library
WIN 55,212-2 - an overview | ScienceDirect Topics
WIN 55,212-2 - Wikipedia
The cannabinoid agonist WIN 55,212-2 (WIN) reversibly inhibits... | Download Scientific Diagram
Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes | ACS Pharmacology & Translational Science
Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids in inflammation: The…
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells | Prostate Cancer and Prostatic Diseases
